Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Evan Meyers Insider Profile
4 Followers
Michael Evan Meyers, Director at COSCIENS Biopharma, holds 408.86K shares in COSCIENS Biopharma (Ticker: CSCI). Most recently, Michael Evan Meyers ― shares of COSCIENS Biopharma on ― for an estimated value of ―.
Profitable Transactions
11 out of 11 Profitable Transactions
Average Return
+57.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Evan Meyers's holdings
Insider Roles
Director
Roles that Michael Evan Meyers holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Evan Meyers
Michael Evan Meyers's Trading History
List of latest transactions for each holding click on a transaction to see Michael Evan Meyers's performance on stock
You May Also Like
Michael Evan Meyers insider profile FAQ
What is the percentage of profitable transactions made by Michael Evan Meyers?
The percentage of profitable transactions made by Michael Evan Meyers is 100%.
What is the average return per transaction made by Michael Evan Meyers?
The average return per transaction made by Michael Evan Meyers is 57.40%.
What stocks does Michael Evan Meyers hold?
Michael Evan Meyers holds: CSCI stocks.
What was Michael Evan Meyers’s latest transaction?
Michael Evan Meyers latest transaction was an Uninformative Buy of ―.
What was Michael Evan Meyers's most profitable transaction?
Michael Evan Meyers’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Evan Meyers's role in COSCIENS Biopharma?
Michael Evan Meyers's role in COSCIENS Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.